Hemophagocytic Lymphohistiocytoses
21
8
9
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
4.8%
1 terminated out of 21 trials
83.3%
-3.2% vs benchmark
10%
2 trials in Phase 3/4
80%
4 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (21)
Prospective Cohort for Adult Hemophagocytosis
Ruxolitinib With De-Intensified HLH-94 for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH)
INTO-HLH: A Disease Registry for Patients With Hemophagocytic Lymphohistiocytosis (HLH)
Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis
Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion
CytOSorb TreatMent Of Critically Ill PatientS Registry
Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
A Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetic Characteristics, and Immunogenicity of Plonmarlimab in Subjects With Rheumatic and Immunological Disease-associated Haemophagocytic Lymphohistiocytosis (HLH) (Also Known as Macrophage Activation Syndrome (MAS))
Prospective Validation of the OHI Index
Evaluation of IFNγ and Inflammatory Mediators in Patients With Hemophagocytic Lymphohistiocytosis
Flow Cytometry for the Study of T-Cell Populations in Hemophagocytic Lymphohistiocytosis Associated With Lymphomas
Modified DEP Regimens for the Treatment of Hemophagocytic Lymphohistiocytosis
A Study on Efficacy and Safety of iNK Cells for CAEBV /EBV-HLH After Allo-HSCT
Early Detection of Epstein-Barr Virus Related Disease.
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Emapalumab in Adult Patients With HLH
Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation
Efficacy and Safety of Carrimycin Tablets in HLH Patients With Carbapenem-resistant Infections
HLH Patients - a Retrospective Study
Response Prediction in EBV-HLH Using Metabonomics Analysis
Sensitivity and Specificity of Cytokines in the Diagnosis of Lymphoma-associated HLH